OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Substance Abuse Treatment is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study	67
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder	64
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail	62
A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts	60
Emergency department interventions for opioid use disorder: A synthesis of emerging models	60
Education and careers were our way out	52
Serial mediation analysis of treatment-specific processes in two contrasting alcohol treatments	40
C2: editorial board	33
What is the relapse risk during treatment? Survivor analysis of single and multiple relapse events in inpatients with alcohol use disorder as part of an observational study	33
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings	32
A randomized clinical trial evaluating the impact of counselor training and patient feedback on substance use disorder patients' sexual risk behavior	32
Can nicotine replacement therapy be personalized? A statistical learning analysis	32
Adapting methadone inductions to the fentanyl era	31
Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform	30
A randomized clinical trial of strengths-based case management to link emergency department patients to opioid use disorder treatment	28
Improving geographic access to methadone clinics	26
Mobile-based brief interventions targeting cannabis-impaired driving among youth: A Delphi study	26
Using machine learning to examine predictors of treatment goal change among individuals seeking treatment for alcohol use disorder	25
The impact of social network dynamics on engagement in drug use reduction programs among men and women who use drugs	25
Recidivism prevention for impaired driving: Longitudinal 5-year outcomes from Quebec's severity-based intervention assignment program	24
Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX	24
Drug court utilization of medications for opioid use disorder in high opioid mortality communities	24
Scoping review of interventions to link individuals to substance use services at discharge from jail	24
Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder	24
Associations between prescription and illicit stimulant and opioid use in the United States, 2015–2020	24

Knowledge, attitudes, and behaviors related to the fentanyl-adulterated drug supply among people who use drugs in Oregon	24
Racial disparities in linkage to care among patients with substance use disorders	23
TOC (update)	23
Developing a cascade of care for opioid use disorder among individuals in jail	23
The impact of COVID-19 on health care professionals who are exposed to drug-related deaths while supporting clients experiencing addiction	23
C2: editorial board	22
C2: editorial board	22
Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?	22
Patient-centered primary care and receipt of evidence-based alcohol-related care in the national Veterans Health Administration	21
Alcohol and drug use among bartenders: An at risk population?	21
Consumer access to buprenorphine and methadone in certified community behavioral health centers: A secret shopper study	19
Client attitudes toward virtual treatment court	18
Opioid relapse and MOUD outcomes following civil commitment for opioid use	17
Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder	17
Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network	17